Logo
Research
Conviction List
Investor Watch
Services
Sign Up
Log In
Upgrade
Search

LIND

RESEARCH


Lind Research provides investor-focused equity research on Nordic companies where we see value. Our coverage is funded by premium subscribers, not issuers, ensuring independence, credibility, and continuity.


LATEST RESEARCH REPORTS & COMMENTS

Date

Report

→

1/8/2026

Physitrack (PTRK): The Thesis Still Holds

→

12/18/2025

Sleep Cycle (SLEEP): Major SDK Licensing Deal Announced

→

12/9/2025

Embracer Group (EMBRACB): 30% Drop Reveals an Attractive Implied Coffee Stain Valuation

→

12/5/2025

Physitrack (PTRK): Extremely Favorable Risk-Reward Situation

→

11/26/2025

Embracer (EMBRACB): Unleashing the GOAT

→

11/26/2025

Physitrack (PTRK): Strategic Restructuring Aligns With Long-Term Value Creation

→

11/14/2025

Embracer (EMBRACB): Soft Quarter Ahead of CSG Spin-Off

→

10/24/2025

Physitrack (PTRK): Market Misses the Cash-Flow and SaaS Quality Shift - Earnings comment

→

10/24/2025

Sleep Cycle (SLEEP): Diversification Gaining Momentum, but Capital Allocation Now Critical - Earnings comment

→

10/17/2025

Better Collective (BETCO): Unlicensed Exposure on HLTV.org

→
More research

Independent | Professional | Unbiased

SUBSCRIBE TO LIND RESEARCH

I consent to receive newsletters via email. Sign up Terms of service.

Lind Research

Home

Subscribe

Upgrade

Terms of Service

Privacy Policy

Research

Company universe

Conviction list

Services

Definitions

Portal

© 2026 Lind Capital Holding AB.

Report abuse

Privacy policy

Terms of use

Powered by beehiiv